{"id":"NCT01235689","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease","officialTitle":"An Open-Label, Multicenter, Efficacy and Safety Study to Evaluate Two Treatment Algorithms in Subjects With Moderate to Severe Crohn's Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-02-11","primaryCompletion":"2016-11-03","completion":"2017-01-03","firstPosted":"2010-11-05","resultsPosted":"2017-12-07","lastUpdate":"2018-01-16"},"enrollment":252,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Crohn's Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Adalimumab","otherNames":["ABT-D2E7","Humira"]},{"type":"DRUG","name":"Prednisone","otherNames":[]},{"type":"DRUG","name":"Azathioprine","otherNames":[]}],"arms":[{"label":"Tight Control Management","type":"EXPERIMENTAL"},{"label":"Clinically Driven Management","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective of this study was to demonstrate that tight control of disease activity, using stringent criteria based on Crohn's disease activity Index (CDAI), biomarkers (high sensitivity C-reactive protein \\[hs-CRP\\] and fecal calprotectin), and corticosteroid use, improves the rate of mucosal healing 48 weeks after randomization compared with management using less stringent criteria based only on CDAI and corticosteroid use.","primaryOutcome":{"measure":"Percentage of Participants With Mucosal Healing and No Deep Ulcerations","timeFrame":"48 weeks after Randomization","effectByArm":[{"arm":"Clinically Driven Management","deltaMin":30.3,"sd":null},{"arm":"Tight Control Management","deltaMin":45.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.010"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["35919766","32224129","31285357","29096949"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":25,"n":122},"commonTop":["NASOPHARYNGITIS","ARTHRALGIA","CROHN'S DISEASE","HEADACHE","ABDOMINAL PAIN"]}}